Show Summary Details
Page of

Two decades of patient advocacy in multiple sclerosis: The success story of the European Multiple Sclerosis Platform 

Two decades of patient advocacy in multiple sclerosis: The success story of the European Multiple Sclerosis Platform
Chapter:
Two decades of patient advocacy in multiple sclerosis: The success story of the European Multiple Sclerosis Platform
Author(s):

Christoph Thalheim

DOI:
10.1093/med/9780198796039.003.0020
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 August 2019

While some national patient self-help and advocacy groups in the field of multiple sclerosis (MS) are looking back on 50 or more years of history, the European Multiple Sclerosis Platform—today the voice of more than 700,000 people with MS gathered in 40 member organizations in 36 European countries—was only created in 1989. During the past 16 years of its active work, advocacy on health and social care policies has gained momentum, with the very first report by the European Parliament on the effects of discriminatory treatment towards persons with MS in 2003. This chapter describes hands-on experiences and gives examples of the value of cooperation between national and European levels in advocacy work for the benefit of people with MS for the past two decades.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.